{
  "trial_id": "NCT00634036",
  "trial_group": "obesity",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, body mass index (BMI), asthma duration, baseline FEV1, baseline leptin levels, baseline adiponectin levels, smoking history, inhaled corticosteroid dose, comorbidities, medication use, baseline airway reactivity (PC20), baseline B-type natriuretic peptide (BNP) levels, pregnancy status, use of contraception, history of asthma exacerbations, history of upper respiratory infections, sleep apnea status, electrocardiogram (ECG) abnormalities.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "Age asthma onset",
          "asthma duration"
        ],
        [
          "FEV1 (% predicted before bronchodilator use)",
          "baseline FEV1"
        ],
        [
          "Asthma exacerbation in last 12 months",
          "history of asthma exacerbations"
        ],
        [
          "Inhaled corticosteroid",
          "inhaled corticosteroid dose"
        ],
        [
          "Oral steroids in last 12 months",
          "medication use"
        ],
        [
          "B-type natriuretic peptide (BNP) >400 pg/mL",
          "baseline B-type natriuretic peptide (BNP) levels"
        ],
        [
          "Women of childbearing potential using oral contraceptives who are not willing to use a second method of contraception during the study",
          "use of contraception"
        ],
        [
          "Pregnant or lactating",
          "pregnancy status"
        ],
        [
          "Clinically significant abnormalities present on screening 12-lead electrocardiogram",
          "electrocardiogram (ECG) abnormalities"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Seasonal allergies",
        "Gastroesophageal Reflux Disease (GERD)",
        "Depression",
        "Oral steroids in last 12 months",
        "Long acting beta agonist",
        "Short acting beta agonist",
        "Exhaled Nitric Oxide",
        "Immunoglobulin E",
        "Juniper Asthma Control",
        "FVC (% predicted before bronchodilator use)",
        "FEV1/FVC (% predicted before bronchodilator use)",
        "FEV1 (% predicted after bronchodilator use)",
        "FVC (% predicted after bronchodilator use)",
        "FEV1/FVC (% predicted after bronchodilator use)"
      ],
      "remaining_candidate_features": [
        "baseline leptin levels",
        "baseline adiponectin levels",
        "smoking history",
        "comorbidities",
        "baseline airway reactivity (PC20)",
        "history of upper respiratory infections",
        "sleep apnea status"
      ]
    },
    "processed-gen-response": "Age, gender, body mass index (BMI), asthma duration, baseline FEV1, baseline leptin levels, baseline adiponectin levels, smoking history, inhaled corticosteroid dose, comorbidities, medication use, baseline airway reactivity (PC20), baseline B-type natriuretic peptide (BNP) levels, pregnancy status, use of contraception, history of asthma exacerbations, history of upper respiratory infections, sleep apnea status, electrocardiogram (ECG) abnormalities."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index, Asthma duration, Baseline FEV1, Methacholine PC20, Inhaled corticosteroid dose, Systolic Blood Pressure, Diastolic Blood Pressure, Leptin levels, Adiponectin levels,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ],
        [
          "FEV1 (% predicted before bronchodilator use)",
          "Baseline FEV1"
        ],
        [
          "Inhaled corticosteroid",
          "Inhaled corticosteroid dose"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Age asthma onset",
        "Seasonal allergies",
        "Gastroesophageal Reflux Disease (GERD)",
        "Depression",
        "Asthma exacerbation in last 12 months",
        "Oral steroids in last 12 months",
        "Long acting beta agonist",
        "Short acting beta agonist",
        "Exhaled Nitric Oxide",
        "Immunoglobulin E",
        "Juniper Asthma Control",
        "FVC (% predicted before bronchodilator use)",
        "FEV1/FVC (% predicted before bronchodilator use)",
        "FEV1 (% predicted after bronchodilator use)",
        "FVC (% predicted after bronchodilator use)",
        "FEV1/FVC (% predicted after bronchodilator use)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Asthma duration",
        "Methacholine PC20",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Leptin levels",
        "Adiponectin levels"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Body Mass Index, Asthma duration, Baseline FEV1, Methacholine PC20, Inhaled corticosteroid dose, Systolic Blood Pressure, Diastolic Blood Pressure, Leptin levels, Adiponectin levels"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, FEV1, Asthma Control Questionnaire (ACQ) score, Methacholine challenge test PC20, Inhaled corticosteroid dose, Weekly weights, B-type natriuretic peptide (BNP) level.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ],
        [
          "FEV1 (% predicted before bronchodilator use)",
          "FEV1"
        ],
        [
          "Inhaled corticosteroid",
          "Inhaled corticosteroid dose"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race (NIH/OMB)",
        "Age asthma onset",
        "Seasonal allergies",
        "Gastroesophageal Reflux Disease (GERD)",
        "Depression",
        "Asthma exacerbation in last 12 months",
        "Oral steroids in last 12 months",
        "Long acting beta agonist",
        "Short acting beta agonist",
        "Exhaled Nitric Oxide",
        "Immunoglobulin E",
        "Juniper Asthma Control",
        "FVC (% predicted before bronchodilator use)",
        "FEV1/FVC (% predicted before bronchodilator use)",
        "FEV1 (% predicted after bronchodilator use)",
        "FVC (% predicted after bronchodilator use)",
        "FEV1/FVC (% predicted after bronchodilator use)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Asthma Control Questionnaire (ACQ) score",
        "Methacholine challenge test PC20",
        "Weekly weights",
        "B-type natriuretic peptide (BNP) level."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, FEV1, Asthma Control Questionnaire (ACQ) score, Methacholine challenge test PC20, Inhaled corticosteroid dose, Weekly weights, B-type natriuretic peptide (BNP) level."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index, smoking history, duration of asthma, FEV1, PC20, inhaled corticosteroid dose, leptin levels, adiponectin levels, B-type natriuretic peptide levels, liver enzymes, serum creatinine, electrocardiogram results.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Body Mass Index",
          "body mass index"
        ],
        [
          "FEV1 (% predicted before bronchodilator use)",
          "FEV1"
        ],
        [
          "Inhaled corticosteroid",
          "inhaled corticosteroid dose"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Age asthma onset",
        "Seasonal allergies",
        "Gastroesophageal Reflux Disease (GERD)",
        "Depression",
        "Asthma exacerbation in last 12 months",
        "Oral steroids in last 12 months",
        "Long acting beta agonist",
        "Short acting beta agonist",
        "Exhaled Nitric Oxide",
        "Immunoglobulin E",
        "Juniper Asthma Control",
        "FVC (% predicted before bronchodilator use)",
        "FEV1/FVC (% predicted before bronchodilator use)",
        "FEV1 (% predicted after bronchodilator use)",
        "FVC (% predicted after bronchodilator use)",
        "FEV1/FVC (% predicted after bronchodilator use)"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "smoking history",
        "duration of asthma",
        "PC20",
        "leptin levels",
        "adiponectin levels",
        "B-type natriuretic peptide levels",
        "liver enzymes",
        "serum creatinine",
        "electrocardiogram results."
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index, smoking history, duration of asthma, FEV1, PC20, inhaled corticosteroid dose, leptin levels, adiponectin levels, B-type natriuretic peptide levels, liver enzymes, serum creatinine, electrocardiogram results."
  }
}